TIMP1 and prostate adenocarcinoma: TIMP-1: Biochemical analysis, in situ hybridization and immunohistochemistry studies have clearly shown that TIMP-1 expression is lost in the tumor tissue of prostate adenocarcinoma cells and many other solid tumors [29,60].